???pagination.result.count???
Inhibition of cardiac HERG potassium channels by antidepressant maprotiline. , Ferrer-Villada T., Eur J Pharmacol. February 15, 2006; 531 (1-3): 1-8.
Chemical modification of the human ether-a- go-go-related gene ( HERG) K+ current by the amino-group reagent trinitrobenzene sulfonic acid. , Jo SH., Arch Pharm Res. April 1, 2006; 29 (4): 310-7.
Molecular determinants of HERG channel block. , Kamiya K., Mol Pharmacol. May 1, 2006; 69 (5): 1709-16.
Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels. , Kiesecker C., Naunyn Schmiedebergs Arch Pharmacol. June 1, 2006; 373 (3): 212-20.
Effect of S5P alpha-helix charge mutants on inactivation of hERG K+ channels. , Clarke CE., J Physiol. June 1, 2006; 573 (Pt 2): 291-304.
Blockade of HERG human K+ channel and IKr of guinea pig cardiomyocytes by prochlorperazine. , Kim MD ., Eur J Pharmacol. August 21, 2006; 544 (1-3): 82-90.
Mutational analysis of block and facilitation of HERG current by a class III anti-arrhythmic agent, nifekalant. , Hosaka Y., Channels (Austin). January 1, 2007; 1 (3): 198-208.
Gambierol, a toxin produced by the dinoflagellate Gambierdiscus toxicus, is a potent blocker of voltage-gated potassium channels. , Cuypers E., Toxicon. May 1, 2008; 51 (6): 974-83.
Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin. , Scherer D., Naunyn Schmiedebergs Arch Pharmacol. July 1, 2008; 378 (1): 73-83.
Electropharmacological properties of telmisartan in blocking hKv1.5 and HERG potassium channels expressed on Xenopus laevis oocytes. , Tu DN., Acta Pharmacol Sin. August 1, 2008; 29 (8): 913-22.
Clomipramine block of the hERG K+ channel: accessibility to F656 and Y652. , Jo SH., Eur J Pharmacol. September 11, 2008; 592 (1-3): 19-25.
[Analysis and analyzing mechanisms of HERG channel kinetics]. , Wang X ., Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. October 1, 2008; 25 (5): 1068-73.
Papaverine, a vasodilator, blocks the pore of the HERG channel at submicromolar concentration. , Kim YJ., J Cardiovasc Pharmacol. December 1, 2008; 52 (6): 485-93.
Discovery of a novel activator of KCNQ1- KCNE1 K channel complexes. , Mruk K., PLoS One. January 1, 2009; 4 (1): e4236.
Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents. , Scherer D., Br J Pharmacol. January 1, 2009; 156 (2): 226-36.
The effects of chiral isolates of methadone on the cardiac potassium channel IKr. , Lin C., Cardiology. January 1, 2009; 113 (1): 59-65.
Extracellular potassium dependency of block of HERG by quinidine and cisapride is primarily determined by the permeant ion and not by inactivation. , Barrows B., Channels (Austin). January 1, 2009; 3 (4): 239-48.
Differential modulation of cardiac potassium channels by Grb adaptor proteins. , Ureche ON., Biochem Biophys Res Commun. June 19, 2009; 384 (1): 28-31.
Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures. , Keller DI., Can J Cardiol. August 1, 2009; 25 (8): 455-62.
H(1) antihistamine drug promethazine directly blocks hERG K(+) channel. , Jo SH., Pharmacol Res. November 1, 2009; 60 (5): 429-37.
Inhibition of the human ether-a- go-go-related gene ( HERG) K+ channels by Lindera erythrocarpa. , Hong HK., J Korean Med Sci. December 1, 2009; 24 (6): 1089-98.
Multiple mechanisms of hERG liability: K+ current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapine. , Obers S., Naunyn Schmiedebergs Arch Pharmacol. May 1, 2010; 381 (5): 385-400.
Response of i(kr) and HERG currents to the antipsychotics tiapride and sulpiride. , Jo SH., Korean J Physiol Pharmacol. October 1, 2010; 14 (5): 305-10.
Recombinant expression of the toxic peptide ErgTx1 and role of Met35 on its stability and function. , Jimenez-Vargas JM., Peptides. March 1, 2011; 32 (3): 560-7.
Kcnh1 voltage-gated potassium channels are essential for early zebrafish development. , Stengel R., J Biol Chem. October 12, 2012; 287 (42): 35565-35575.
Blocking of the human ether-à- go-go-related gene channel by imatinib mesylate. , Dong Q., Biol Pharm Bull. January 1, 2013; 36 (2): 268-75.
Regulation of human cardiac potassium channels by full-length KCNE3 and KCNE4. , Abbott GW., Sci Rep. December 6, 2016; 6 38412.
Bioelectric signaling: Reprogrammable circuits underlying embryogenesis, regeneration, and cancer. , Levin M ., Cell. April 15, 2021;